VeriMomБезопасен ли s-spider oligopeptide-1 при беременности?
No harmonised CLP classification (ECHA Annex VI) or SCCS/CIR reproductive safety finding for oligopeptide-1/EGF; no human teratogenic data. Peptides such as EGF are large biomolecules with low expected dermal penetration and no published reproductive hazard signals in regulatory sources or the peer-reviewed literature searched (PubMed). Sources: ECHA Annex VI (no harmonised classification), PubMed (no reproductive hazard publications), CosIng/PubChem (ingredient identity and peptide nature).
Related ingredients
Frequently asked questions
- Безопасен ли s-spider oligopeptide-1 при беременности?
- No harmonised CLP classification (ECHA Annex VI) or SCCS/CIR reproductive safety finding for oligopeptide-1/EGF; no human teratogenic data. Peptides such as EGF are large biomolecules with low expected dermal penetration and no published reproductive hazard signals in regulatory sources or the peer-reviewed literature searched (PubMed). Sources: ECHA Annex VI (no harmonised classification), PubMed (no reproductive hazard publications), CosIng/PubChem (ingredient identity and peptide nature).
- Безопасен ли s-spider oligopeptide-1 при грудном вскармливании?
- No regulatory or peer-reviewed evidence of reproductive or lactation-specific hazards for oligopeptide-1/EGF. As a peptide with low systemic absorption from topical use, there is no demonstrated mechanism or data indicating transfer into breast milk or lactation-related effects in mother or infant. Sources: CIR/SCCS databases (no adverse findings), PubMed (no lactation transfer data indicating hazard), CosIng.
- Безопасен ли s-spider oligopeptide-1 для кожи малыша?
- Hazard and mechanism: no evidence of developmental or reproductive toxicity specific to infants. Exposure: while adult dermal absorption is expected to be negligible for a large peptide (adult e=0), infant skin has higher surface-area-to-weight and an immature barrier so exposure is plausibly higher; therefore exposure score increased by +1 to e=1 for 0–3 yr skin. No infant-specific adverse data were identified in PubMed or regulatory sources. Sources: PubMed (no infant toxicity reports), CosIng, ECHA (no harmonised classification).
- Как VeriMom оценивает s-spider oligopeptide-1?
- VeriMom оценивает s-spider oligopeptide-1 в 100/100 (без известных рисков) на основе EU CosIng, классификаций ECHA и исследований PubMed.
- Какие безопасные альтернативы s-spider oligopeptide-1 при беременности?
- См. наш список безопасных альтернатив s-spider oligopeptide-1 с аналогичной функцией и классификацией без известных рисков.
Проверь любой состав за 2 секунды
Скачай VeriMom бесплатно — отсканируй любой продукт и мгновенно получи оценку безопасности при беременности.
Медицинская оговорка
Данная информация предоставлена исключительно в образовательных целях и не является медицинской рекомендацией. Оценки безопасности основаны на общедоступных данных и могут не отражать все риски. Всегда консультируйтесь с вашим врачом перед использованием любых средств во время беременности или грудного вскармливания.